Debates regarding the legalization of cannabis for medicinal and recreational purposes have been going around for years now. While the numerous health benefits of the plant haven’t gone unnoticed, many governments are still skeptical about taking this bold decision.
The Canadian government, however, realized the need of this incredible plant, and therefore, issued the Cannabis act, which declared that by October 17th, 2018, the selling, distribution, and possession of Cannabis for adults was allowed by law, provided that all products were bought and sold from governmentally authorized practitioners.
Following this announcement many Cannabis producers have emerged into the field, but Zenabis is, by far, the largest Licensed Cannabis producer that’s hit the market.
What is Zenabis?
Zenabis is the brand-new Canadian cannabis company that has grown up to be the largest Licensed Producers of medical cannabis in Canada. The company is the only coast-to-coast Licensed Producer in the country with a 25,000 square foot facility in Delta, British Columbia and a 380,000 square foot facility in Athol Ville,
New Brunswick. In total, these facilities encompass 660,000 square feet of indoor pharmaceutical grade cannabis production space and are equipped with state-of-the-art technology. The facilities are strategically positioned on Canada’s coasts, facilitating national distribution and access to international markets.
On October 4th, 2018, the company signed an Arrangement Agreement with Bevo Agro Inc. that involved a reverse take-over of Bevo. The transaction stated that Bevo was to change its name to Zenabis Global Inc.
This transaction was unanimously approved by the board of directors of Bevo as well as a vast majority of shareholders, who voted their Bevo common shares in favor of the Transaction.
The agreement also explained that Bevo’s greenhouse facilities in Langley would be expanded and retrofitted to integrate advanced propagation technologies and state-of-the-art lighting and ventilation systems following the completion of the Transaction.
Our primary goal with this merger is to expand Zenabis’ capacity to supply high-quality cannabis for worldwide distribution,” stated CEO Rick Brar in a press release.
By October 15, 2018, Zenabis had secured purchase orders from government and third-party retailers/distributors in New Brunswick, Nova Scotia, British Columbia, Yukon, and Europe.
On October 16th, the company announced that they had signed an LOI with Hillsboro Corp Inc. to develop cannabis-infused kombucha. With this deal, Zenabis intends to work with the company in producing and distributing cannabis-infused refined tea beverage products to the Canadian population.
What’s the aim of Zenabis?
Being one of the largest Cannabis producers, Zenabis aims to provide medicinal as well as recreational cannabis products to the people of Canada (and worldwide). They have a passionate and progressive team that helps innovate new ideas into reality.
The company takes pride in benefiting thousands of people across Canada that suffer from conditions that can be treated with this miraculous plant. Their goal is to provide, legal, safe and high-quality cannabis products and derivatives to the millions of Canadians that want them.
The company also engages actively in patient education, physician counseling, community outreach, and building public awareness about cannabis and cannabis derivatives. This has helped the community on a whole new level, with many patients now fearlessly opting for cannabis-related medications.
It can be said without any doubt that Zenabis has- with is brilliant faculty and growing techniques secured an essential position in the local and worldwide cannabis market.
What are cannabis products available at Zenabis?
As of now, six different cannabis products are available at Zenabis for medicinal applications. Once you register with the company, you can purchase products.
Registration is an easy, 2-step procedure that involves first registering to the website (either online or by filling an application form that can be sent via email, fax or mail) and then asking your concerned Doctor or Nurse Practitioner to complete the Medical Document and submit it on your behalf. After registration, the patients have access to the following cannabis products;
• Belladonna ($8.25 / gram)
This product has moderate amounts of THC (11.27%) and is for patients who have not taken cannabis products previously. The CBD content of Belladonna is <0.64%. 60% of the product is derived for sativa, while the rest 40% is extraction is done from the Indica species.
• Sensi star ($8.75/ gram)
This product contains 18.98% THC, while only <0.01% CBD. It is an Indica dominant product that has 90% Indica and only 10% sativa. The unique features of Sensi Star include crystalline trichomes and dark green colors. It has an earthy aroma with accents similar to the smells of wood. Because the product has such high levels of THC, patients are advised to start with low dosages.
• Wappa ($8.50/ gram)
Wappa is 40% Sativa and 60% Indica. It has about 14-18% THC, and only about <0.064% CBD. The product has a vibrant, frosty, lime-colored appearance, with a medley of amber stigmas. Since this product has high levels of THC, patients are advised to be cautious with the dosages.
• Ultra sour ($9.50/ gram)
Ultra Sour is a sativa dominant strain (70% Sativa), light green with small orange hairs. The product has very high THC levels (22.29%), compared to low CBD levels of only 0.06%. Patients consuming Ultra sour are recommended to take only small dosages.
• Shishkaberry ($8.50/gram)
Shishkaberry, with its prominent smell of sweet berries, contains 15.03% THC and 0.06% CBD. The product is Indica dominant (80%) and only has 20% Sativa.
• Durga Mata 2 ($9.00/ gram)
Durga Mata 2 is an Indica dominant hybrid strain. It is derived 90% from the Indica species of the cannabis plant, and only 10% from the sativa species. Compared to all Zenabis products, Durga Mata 2 is the only product that has relatively higher levels of CBD (12.36%) and lower levels of THC (6.44%). This product is a good option for new patients looking for an even ratio.
Zenabis Products that are coming soon
Because the company is still new, it has to launch many new products yet. Among them, one is ‘Mk Ultra,’ which will contain exceedingly high levels of THC (20-25%) and low levels of CBD (<0.1%). This product will be Indica dominant, with 90% Indica and only 10% sativa.
Moreover, the company is also supposed to announce three different Cannabis oils with each one of them having unique properties. The first type will be Purely THC, the second variety will be purely CBD, while the third one will possess an equal blend of both THC and CBD.
Zenabis products for recreational uses- Namaste Zenabis Products that are aimed for users who are seeking the recreational uses of Cannabis are launched under the brand name of Namaste. This new line of adult use products was officially introduced to store shelves on October 17th, 2018 in New Brunswick, Nova Scotia, and British Columbia.
The company also has purchase orders from the Yukon Territory, and there are plans for additional markets to follow. The Namaste products, which are crafted with the same exceptional quality found in Zenabis medical offerings, are aimed to deliver a premium experience for consumers. Dr. Natasha Ryz, Chief Science Officer,
Zenabis, commented that she was hopeful that Namaste’s thoughtful and responsible approach to cannabis will help break down age-old stigmas surrounding cannabis use. While the brand only provides dried flowers, milled and pre-rolled cannabis so far, more items will be available shortly.